Pro-Dex Inc New (PDEX)

Price$65.21

Value ScoreC

Growth ScoreB

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)71.03%

Price vs S&P 500 (4W)10.03%

VGM Score65.13

Market Capitalization$208.20M

P/E Ratio (Annual)23.19x

All Metrics

Book Value / Share (Quarterly)$14.14

P/TBV (Annual)3.89x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)16.57%

Cash Flow / Share (Quarterly)$2.18

Price vs S&P 500 (YTD)61.31%

Gross Margin (TTM)27.78%

Net Profit Margin (TTM)16.08%

EPS (TTM)$3.63

10-Day Avg Trading Volume0.05M

EPS Excl Extra (TTM)$3.63

Revenue Growth (5Y)13.84%

EPS (Annual)$2.67

ROI (Annual)17.26%

Gross Margin (Annual)29.30%

Net Profit Margin (5Y Avg)11.97%

Cash / Share (Quarterly)$3.43

P/E Basic Excl Extra (TTM)17.35x

Revenue Growth QoQ (YoY)14.56%

EPS Growth (5Y)12.27%

P/E Normalized (Annual)23.19x

ROA (Last FY)14.67%

Revenue Growth TTM (YoY)16.39%

EBITD / Share (TTM)$3.65

ROE (5Y Avg)20.50%

Operating Margin (TTM)14.48%

Cash Flow / Share (Annual)$-0.90

P/B Ratio4.61x

P/B Ratio (Quarterly)3.48x

Net Income / Employee (Annual)$49,600

EV / Revenue (TTM)2.90x

Net Interest Coverage (TTM)1.58x

ROA (TTM)18.27%

EPS Growth QoQ (YoY)22.74%

EV / EBITDA (TTM)17.90x

EPS Incl Extra (Annual)$2.67

Current Ratio (Annual)3.23x

Quick Ratio (Quarterly)2.10x

3-Month Avg Trading Volume0.03M

52-Week Price Return54.42%

EV / Free Cash Flow (Annual)10.00x

P/E Incl Extra (TTM)17.35x

Revenue / Employee (TTM)$412,400

Tangible BV / Share (Quarterly)$13.92

P/S Ratio (Annual)3.13x

Asset Turnover (Annual)1.09x

52-Week High$68.99

Operating Margin (5Y Avg)13.19%

EPS Excl Extra (Annual)$2.67

CapEx CAGR (5Y)19.10%

Tangible BV CAGR (5Y)14.12%

26-Week Price Return78.95%

Quick Ratio (Annual)1.69x

13-Week Price Return36.97%

Total Debt / Equity (Annual)0.42x

Current Ratio (Quarterly)3.67x

Enterprise Value$216.70M

Revenue / Share Growth (5Y)18.34%

Asset Turnover (TTM)1.14x

Book Value / Share Growth (5Y)17.55%

Revenue / Employee (Annual)$367,900

Inventory Turnover (Annual)2.51x

Pretax Margin (Annual)18.11%

Cash / Share (Annual)$2.20

3-Month Return Std Dev47.47%

Gross Margin (5Y Avg)30.18%

Net Income / Employee (TTM)$66,300

EBITDA CAGR (5Y)9.32%

EBITDA Interim CAGR (5Y)11.02%

ROE (Last FY)24.51%

Net Interest Coverage (Annual)9.85x

EPS Basic Excl Extra (Annual)$2.67

P/FCF (TTM)28.78x

Receivables Turnover (TTM)4.21x

EV / Free Cash Flow (TTM)31.10x

Total Debt / Equity (Quarterly)0.41x

EPS Incl Extra (TTM)$3.63

Receivables Turnover (Annual)4.36x

ROI (TTM)21.57%

P/S Ratio (TTM)2.79x

Pretax Margin (5Y Avg)15.41%

Revenue / Share (Annual)$19.81

Tangible BV / Share (Annual)$11.23

Forward P/E22.30x

Price vs S&P 500 (52W)30.05%

P/E Ratio (TTM)17.35x

EPS Growth TTM (YoY)29.42%

Year-to-Date Return69.46%

5-Day Price Return-2.57%

EPS Normalized (Annual)$2.67

ROA (5Y Avg)11.39%

Net Profit Margin (Annual)13.48%

Month-to-Date Return0.68%

Cash Flow / Share (TTM)$1.76

EBITD / Share (Annual)$3.55

EPS Growth (3Y)30.01%

Operating Margin (Annual)16.05%

LT Debt / Equity (Annual)0.25x

P/CF (TTM)28.36x

ROI (5Y Avg)13.74%

P/E Excl Extra (TTM)17.35x

LT Debt / Equity (Quarterly)0.32x

EPS Basic Excl Extra (TTM)$3.63

P/TBV (Quarterly)3.54x

P/B Ratio (Annual)3.88x

Inventory Turnover (TTM)2.35x

Pretax Margin (TTM)21.56%

Book Value / Share (Annual)$11.23

Price vs S&P 500 (13W)28.71%

Net Margin Growth (5Y)-5.13%

Beta0.01x

P/FCF (Annual)39.73x

Revenue / Share (TTM)$22.83

ROE (TTM)29.10%

52-Week Low$23.47

vGradeC

gGradeB

mGradeB

vgmGradeB

Show chart for

Earnings Surprise History

Q3 261.20est. 0.63

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

Jun 2026

4.14

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
PDEXPro-Dex Inc New	C	B	B	$65.21
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

Pro-Dex designs and manufactures powered surgical instruments for medical device OEMs globally, specializing in autoclavable, battery-powered drivers and shavers used in orthopedic, thoracic, and craniomaxillofacial procedures. The company also provides engineering and regulatory consulting services and manufactures rotary air motors for industrial applications. Based in ISO-certified California facilities, Pro-Dex serves hospitals, medical labs, and manufacturers worldwide.